These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25511180)

  • 1. Disruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata.
    Bosson A; Boisseau S; Buisson A; Savasta M; Albrieux M
    Glia; 2015 Apr; 63(4):673-83. PubMed ID: 25511180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism.
    Sitzia G; Mantas I; Zhang X; Svenningsson P; Chergui K
    Neuropharmacology; 2020 Sep; 174():108136. PubMed ID: 32474027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus electrical stimulation modulates calcium activity of nigral astrocytes.
    Barat E; Boisseau S; Bouyssières C; Appaix F; Savasta M; Albrieux M
    PLoS One; 2012; 7(7):e41793. PubMed ID: 22848608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.
    Aono H; Choudhury ME; Higaki H; Miyanishi K; Kigami Y; Fujita K; Akiyama JI; Takahashi H; Yano H; Kubo M; Nishikawa N; Nomoto M; Tanaka J
    Glia; 2017 Nov; 65(11):1833-1847. PubMed ID: 28836295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata.
    Wittmann M; Marino MJ; Conn PJ
    J Pharmacol Exp Ther; 2002 Aug; 302(2):433-41. PubMed ID: 12130700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal Firing and Glutamatergic Synapses in the Substantia Nigra Pars Reticulata of LRRK2-G2019S Mice.
    Sitzia G; Skiteva O; Chergui K
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
    Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
    Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor.
    Antonazzo M; Gomez-Urquijo SM; Ugedo L; Morera-Herreras T
    Neurobiol Dis; 2021 Jan; 148():105214. PubMed ID: 33278598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
    Cáceres-Chávez VA; Hernández-Martínez R; Pérez-Ortega J; Herrera-Valdez MA; Aceves JJ; Galarraga E; Bargas J
    J Neurophysiol; 2018 Dec; 120(6):2922-2938. PubMed ID: 30256736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential calcium channel-mediated dopaminergic modulation in the subthalamonigral synapse.
    Robles-Gómez AA; Vega AV; Florán B; Barral J
    Synapse; 2020 Jul; 74(7):e22149. PubMed ID: 31975491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
    Delaville C; Navailles S; Benazzouz A
    Neuroscience; 2012 Jan; 202():424-33. PubMed ID: 22138505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat.
    Sutton AC; Yu W; Calos ME; Smith AB; Ramirez-Zamora A; Molho ES; Pilitsis JG; Brotchie JM; Shin DS
    J Neurophysiol; 2013 Jan; 109(2):363-74. PubMed ID: 23076106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat.
    Abedi PM; Delaville C; De Deurwaerdère P; Benjelloun W; Benazzouz A
    Neuroscience; 2013 Apr; 236():289-97. PubMed ID: 23376117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.
    Sgambato-Faure V; Cenci MA
    Prog Neurobiol; 2012 Jan; 96(1):69-86. PubMed ID: 22075179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
    Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
    Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats.
    Chung EK; Chen LW; Chan YS; Yung KK
    J Comp Neurol; 2008 Dec; 511(4):421-37. PubMed ID: 18831527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.